Virtual Clinical Trials Market Size, Share & Trends Analysis Report By business Mode of Clinical Trial (Hybrid Clinical Trial and Fully Virtual Clinical Trial), Study Type (Interventional, Observational, Expanded Access), Type Of Therapeutic Area, Clinical Trial Phase, Company Size, End-User, Region And Segment Forecasts, 2023-2031
Segmentation of Virtual Clinical Trials Market-
By Mode of Clinical Trial
- Hybrid Clinical Trial
- Fully Virtual Clinical Trial
By Study Type
- Interventional
- Observational
- Expanded Access
By Type of Therapeutic Area
- Cardiovascular Disorders
- Infectious Diseases
- Metabolic Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
- Other Disorders
By Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
By Company Size
- Small
- Mid-sized
- Large
By End Users
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Medical Device Industries
- Other End Users
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Virtual Clinical Trials Market Snapshot
Chapter 4. Global Virtual Clinical Trials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Mode of Clinical Trial Estimates & Trend Analysis
5.1. by Mode of Clinical Trial & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Mode of Clinical Trial:
5.2.1. Hybrid Clinical Trials
5.2.2. Fully Virtual Clinical Trials
Chapter 6. Market Segmentation 2: by Study Type Estimates & Trend Analysis
6.1. by Study Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Study Type:
6.2.1. Interventional
6.2.2. Observational
6.2.3. Expanded Access
Chapter 7. Market Segmentation 3: by Type of Therapeutic Area Estimates & Trend Analysis
7.1. by Type of Therapeutic Area & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Therapeutic Area:
7.2.1. Cardiovascular Disorders
7.2.2. Infectious Diseases
7.2.3. Metabolic Disorders
7.2.4. Neurological Disorders
7.2.5. Oncological Disorders
7.2.6. Respiratory Disorders
7.2.7. Other Disorders
Chapter 8. Market Segmentation 4: by Clinical Trial Phase Estimates & Trend Analysis
8.1. by Clinical Trial Phase & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Clinical Trial Phase:
8.2.1. Phase I
8.2.2. Phase II
8.2.3. Phase III
8.2.4. Phase IV
Chapter 9. Market Segmentation 5: by Company Size Estimates & Trend Analysis
9.1. by Company Size Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Company Size:
9.2.1. Small
9.2.2. Mid-sized
9.2.3. Large
Chapter 10. Market Segmentation 6: by End Users Estimates & Trend Analysis
10.1. by End Users & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Users:
10.2.1. Pharmaceutical and Biotechnology Companies
10.2.2. Academic and Research Institutes
10.2.3. Medical Device Industries
10.2.4. Other
Chapter 11. Virtual Clinical Trials Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.1.2. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.1.3. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.1.4. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.1.5. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.1.6. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.1.7. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.2. Europe
11.2.1. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.2.2. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.2.3. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.2.4. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.2.5. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.2.6. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.2.7. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.3.2. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.3.3. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.3.4. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.3.5. Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.3.6. Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.3.7. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.4. Latin America
11.4.1. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.4.2. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.4.3. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.4.4. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.4.5. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.4.6. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.4.7. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.5.2. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.5.3. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Type of Therapeutic Area, 2023-2031
11.5.4. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.5.5. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.5.6. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.5.7. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Fortrea
12.2.2. IQVIA
12.2.3. KORE Wireless
12.2.4. Labcorp
12.2.5. Medpace
12.2.6. Parexel
12.2.7. PPD
12.2.8. Syneos Health
12.2.9. Signant Health
12.2.10. Veeva
12.2.11. Cambridge Cognition
12.2.12. Medidata Solutions
12.2.13. PanAmerican Clinical Research
12.2.14. Science 37
12.2.15. Other Prominent Players
12.2.15.1. CareShare
12.2.15.2. Clariness
12.2.15.3. Cliniv
12.2.15.4. Clinscience
12.2.15.5. CMIC
12.2.15.6. DynamiQ Health
12.2.15.7. Emovis
12.2.15.8. Ergomed
12.2.15.9. Flatworld Solutions
12.2.15.10. Gsap
12.2.15.11. Hexaware Technologies
12.2.15.12. Huma
12.2.15.13. ICON
12.2.15.14. Kayentis
12.2.15.15. Tata Consultancy Services
12.2.15.16. Viedoc
12.2.15.17. WeGuide
12.2.15.18. Wren Healthcare
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Virtual Clinical Trials Market Size is valued at USD 14.8 billion in 2023 and is predicted to reach USD 26.3 billion by the year 2031
Virtual Clinical Trials Market is predicted to develop at a 7.6% CAGR during the forecast period for 2024-2031.
Parexel International Corporation; IQVIA; Covance; PRA Health Sciences; LEO Innovation Lab; Medidata; Oracle; CRF Health; Clinical Ink; Medable, Inc;